| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Pilot Clinical Trial of NT-3 in CMT1A Patients | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 7 |
| 2 | The Phase II Futility Clinical Trial Design | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 5 |
| 3 | Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 3 |
| 4 | A Double-Blind, Randomized Clinical Trial to Assess the Augmentation with Nimodipine of Antidepressant Therapy in the Treatment of “Vascular Depression” | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 3 |
| 5 | The NIMH MATRICS Initiative: Development of a Consensus Cognitive Battery | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 3 |
| 6 | Radiotherapy with Concurrent and Adjuvant Temozolomide: A New Standard of Care for Glioblastoma Multiforme | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 2 |
| 7 | Liquid Fluoxetine versus Placebo for Repetitive Behaviors in Childhood Autism | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 2 |
| 8 | Targeting Amyloid with Tramiprosate in Patients with Mild-to-Moderate Alzheimer Disease | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 2 |
| 9 | Triflusal versus Aspirin for the Prevention of Stroke | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 2 |
| 10 | Insulin Resistance Alzheimer's Disease: Pathophysiology and Treatment | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 2 |
| 11 | Early Phase Trials of Minocycline in Amyotrophic Lateral Sclerosis | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 1 |
| 12 | Efficacy and Tolerability of Ziprasidone and Olanzapine in Acutely Ill Inpatients with Schizophrenia or Schizoaffective Disorder: Results of a Double-Blind, Six-WeekStudy, with a Six-Month, Double-Blind Continuation Phase | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 1 |
| 13 | AVP-923 as a Novel Treatment for Pseudobulbar Affect in ALS | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 1 |
| 14 | Effect of Methylphenidate in Patients with Acute Traumatic Brain Injury; a Randomized Clinical Trial | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 1 |
| 15 | The Argatroban and tPA Stroke Study | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 1 |
| 16 | Randomized Clinical Trials of Pregabalin for Neuropathic Pain: Methods, Results, and Implications | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 1 |
| 17 | Tetrathiomolybdate versus Trientine in the Initial Treatment of Neurologic Wilson's Disease | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 1 |
| 18 | A Randomized-Controlled Trial of Bilateral rTMS for Treatment-Resistant Depression | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 1 |
| 19 | Improvement in Speeded Cognitive Processing After Anti-epileptic Drug Withdrawal – A Controlled Study in Mono-therapy Patients | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 1 |
| 20 | Introduction to Neurotherapeutics and Neuropsychopharmacology | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 0 |
| 21 | Modafinil for the Treatment of Fatigue in Multiple Sclerosis | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 0 |
| 22 | Treating Migraine Attacks ASAP: Concept and Methodological Issues | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 0 |
| 23 | Creatine as a Potential Treatment for Amyotrophic Lateral Sclerosis | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 0 |
| 24 | Selegiline in the Treatment of Negative Symptoms of Schizophrenia | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 0 |
| 25 | Analysis of the Cognitive Enhancing Effects of Modafinil in Schizophrenia | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 0 |
| 26 | Testing Multiple Novel Mechanisms for Treating Schizophrenia in a Single Trial | Progress in Neurotherapeutics and Neuropsychopharmacology | 2006 | 0 |
| 27 | Chemoradiotherapy for primary CNS lymphoma | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 28 | Can Quality of Life be Improved in Schizophrenia? Results From A Pragmatic, Randomized, Controlled Trial Comparing Olanzapine with First Generation Antipsychotics | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 29 | Repetitive Transcranial Magnetic Stimulation: A Novel, Noninvasive Add-on Treatment for Medication-Resistant Depression | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 30 | Symptomatic Remission in Patients with Bipolar Mania: Results from a Double-Blind, Placebo-Controlled Trial of Risperidone Monotherapy | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 31 | Clinical Trials in Dementia | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 32 | Progress in Neurotherapeutics and Neuropsychopharmacology 2007 | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 33 | A Randomized Trial Comparing Unilateral Pallidotomy with Bilateral Subthalamic Nucleus Stimulation in PD: Perspectives for Future Implication in Clinical Practice | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 34 | New Directions in Pediatric Neuro-Oncology Practice: Impact of the Children's Cancer Group Study 9933, a Phase II Study of High-Dose Chemotherapy Before Radiation in Children with Newly Diagnosed High-Grade Astrocytoma | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 35 | Trial-Based Advances in the Treatment of Bipolar Depression | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 36 | Combined Behavioral and Pharmacological Treatment of Opioid-Dependent Adolescents: A Randomized, Controlled Trial | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 37 | Olanzapine as Maintenance Therapy in Patients with Bipolar I Disorder | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 38 | Review of a Randomized-Controlled Trial of Adjunctive Bupropion in the Treatment of SSRI-Induced Sexual Dysfunction | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 39 | Comparative Neuropsychological Effects of Lamotrigine and Topiramate in Healthy Volunteers | Progress in Neurotherapeutics and Neuropsychopharmacology | 2007 | 0 |
| 40 | Modafinil: A Candidate for Pharmacotherapy of Negative Symptoms in Schizophrenia | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 41 | Optimal Dosing of Immunomodulating Drugs: A Dose-Comparison Study of GA in RRMS | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 42 | Ropinirole 24-h Prolonged Release in Advanced Parkinson Disease: Review of a Randomized, Double-Blind, Placebo-Controlled Study (EASE PD - Adjunct Study) | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 43 | Night Eating Syndrome and Results from the First Placebo-Controlled Trial of Treatment, with the SSRI Medication, Sertraline: Implications for Clinical Practice | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 44 | New Approaches to Treatment of Schizophrenia by Enhancing N-methyl-D-aspartate Neurotransmission | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 45 | Progress in Neurotherapeutics and Neuropsychopharmacology 2008 | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 46 | Use of Selegiline as Monotherapy and in Combination with Levodopa in the Management of Parkinson's Disease: Perspectives from the MONOCOMB Study | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 47 | Intranasal Zolmitriptan Is Effective and Well Tolerated in Acute Cluster Headache: A Randomized Placebo-Controlled Double-Blind Crossover Study | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 48 | Serotonin Related Genes Affect Antidepressant Treatment in Obsessive–Compulsive Disorder | Progress in Neurotherapeutics and Neuropsychopharmacology | 2008 | 0 |
| 49 | The Phase II Futility Clinical Trial Design | Progress in Neurotherapeutics and Neuropsychopharmacology | 0 | 0 |
